Cardiovascular Business Articles

13.5M in the US can’t name a single heart attack symptom

Millions of Americans are unaware of common heart attack symptoms, according to researchers, including a subset of 13.5 million people who admit to not knowing a single symptom of MI.

Benefits of anticoagulation decrease with age in AFib patients

The net clinical benefit (NCB) of anticoagulants like warfarin and apixaban slows over time in patients with atrial fibrillation, according to a Circulation: Cardiovascular Quality and Outcomes study, diminishing as people age and face competing risks of death.

West Virginia achieves 1st-ever heart transplant

A 61-year-old patient at the West Virginia University Heart and Vascular Institute is the first in the state to receive a successful heart transplant, WVU reported Nov. 10.

Long-term survival poor in patients with moderate, severe AS

Both severe and moderate aortic stenosis (AS), when left untreated, were associated with poor long-term survival in a large-scale study of Australian heart patients.

Multiarterial CABG deemed superior to single-arterial approach

Multiarterial coronary artery bypass grafting (CABG) was linked to lower rates of long-term mortality, reintervention and MI than single-arterial CABG in a recent study of heart patients, suggesting the multiarterial approach is underused in contemporary practice.

Behavioral therapy plus liraglutide optimizes QOL in obese patients

A study out of the University of Pennsylvania School of Nursing suggests that weight loss achieved through a combination of intensive behavioral therapy (IBT) and 3 milligrams of liraglutide daily results in optimal weight-related quality of life for patients struggling with obesity.

CMS rule expands coverage of PCI at ambulatory centers

CMS has finalized a rule that states, come Jan. 1, it will begin paying for certain percutaneous coronary interventions (PCIs) performed at ambulatory surgical centers (ASCs) in the U.S.

Performance Report: The Critical Characteristics of High-performing Cardiology Programs

High-performing cardiology programs set the standard for patient care with respect to quality, resource utilization and patient as well as physician satisfaction.

Zantac recalls just ‘the tip of the iceberg’ for CV drug impurities

It’s been more than six weeks since Zantac and generic formulas of ranitidine were pulled from pharmacy shelves due to carcinogenic impurities, but physicians in Pittsburgh aren’t convinced the recalls are over.

‘Tons of information but not nearly enough wisdom’: The state of cardiology in 2019

The past year has seen a whole lot of change for the field of cardiology, but it’s hard to discern where that leaves us as we prepare for 2020. MedAxiom President Jerry Blackwell, MD, MBA, helped clarify the situation at the organization’s annual fall meeting this October.

X